Cold Plasma Market Research Report 2024

Cold Plasma Market Segment Analysis:

The cold Plasma market is segmented on the basis of Regime Type, Technology, Application, End-user.

By Regime Type, Low-pressure Segment Is Expected to Dominate the Market During the Forecast Period

There are two segments such as low-pressure and atmospheric pressure. Among these, the low-pressure segment is expected to dominate the market during the forecast period.

• Low-pressure cold plasma's precision and control make it desirable in healthcare, food, agriculture, textiles, and electronics, leading to high demand. Rising market for low-pressure plasma in India and China, fueled by industrialization, higher incomes, and manufacturing advancements, will drive growth.
• Low-pressure cold plasma is a popular option in medical industries for disinfecting equipment and treating wounds because it can effectively sterilize without causing harm to products.
• Low-pressure plasma is a safer option for human use compared to atmospheric-pressure plasma because it is more controllable and less hazardous. This feature makes it an attractive choice for medical and personal care items.
• Developments in low-pressure plasma technology provide effective and economical solutions, prompting companies and manufacturers to put money into this advanced technology.

By Application, Wound Healing Segment Held the Largest Share In 2023

There are five segments by application such as wound healing, cancer treatment, dentistry, wastewater treatment, and seed germination. Among these, the wound healing segment held the largest share in 2023.

• Cold plasma speeds up wound healing by enhancing cell movement, growth, and blood vessel formation. It triggers growth factor release and changes the wound environment, aiding tissue repair. Its benefits make it ideal for treating challenging wounds.
• Cold plasma, which has antimicrobial properties, fights infections in chronic wounds, promoting a sterile environment and accelerating the healing process. Avoids interruptions due to the multiplication of bacteria.
• Cold plasma wound healing is not invasive and is well tolerated, in contrast to traditional therapies that can cause discomfort or pain for patients. The diverse uses of cold plasma in healing diabetic ulcers, burns, surgical wounds, and pressure ulcers add value in various healthcare environments.
• Increasing numbers of chronic wounds highlight the necessity for successful healing remedies. Cold plasma holds potential for tackling the difficulties posed by diabetic ulcers and venous leg ulcers.

• This pie chart shows that cold plasma is mainly used in wound healing (40%) and followed by cancer treatment (25%).

Cold Plasma Market Regional Insights:

Asia Pacific is Expected to Dominate the Market Over the Forecast Period

• The rapid industrial growth in Asia Pacific, especially in China and India, drives production in industries such as electronics, automotive, healthcare, and textiles. The use of cold plasma is essential for tasks such as surface cleaning, activation, and modifying materials, making it popular in industries in the region.
• Cold plasma is becoming more and more common in the healthcare industry for treating wounds, battling cancer, and sterilizing equipment. The cold plasma market is experiencing growth due to the region's investments in healthcare and increased demand for advanced technologies.
• Asia Pacific, possessing the largest population globally, presents a substantial market for various industries. Increased population density results in health issues, which heighten the demand for advanced medical treatments such as cold plasma.
• In countries such as Japan, South Korea, and China in Asia Pacific, cold plasma technologies are quickly progressing with research institutions, universities, and companies actively participating, driving innovation, productivity, and investment across different sectors.

Cold Plasma Market Active Players

• Nordson Corporation (U.S.)
• Europlasma NV (Belgium)
• Plasmatreat GmbH (Germany)
• Terraplasma Medical GmbH (Germany)
• Henniker Plasma (United Kingdom)
• US Medical Innovations (United States)
• Molecular Plasma Group (United States)
• Adtec Plasma Technology Co Ltd. (Japan)
• Smith & Nephew plc. (United Kingdom)
• Thierry Corporation (United States)
• AcXys Plasma Technologies (France)
• Apyx Medical (United States)
• Coating Plasma Innovation (France)
• Enercon Industries Corporation (United States)
• P2i Limited (United Kingdom)
• Neoplas GmbH (Germany)
• Softal Corona & Plasma GmbH (Germany)
• Surfx Technologies, LLC (United States)
• Tantec A/S (Denmark)
• Plasma Etch, Inc. (United States)
• 3M Company (United States)
• Coloplast A/S (Denmark)
• Baxter International Inc. (United States)
• Covidien PLC. (Medtronic plc.) (Ireland/United States)
• Ethicon, Inc. (Johnson & Johnson) (United States), and Other Active Players.

Key Industry Developments in the Cold Plasma Market:

• In May 2024, Tianqi Zhang at the University of Sydney and one of the study’s scientists announced that for the first time, scientists have transformed the carbon in biogas into long-chain hydrocarbons using a cold plasma. Biogas, a mixture of carbon dioxide and methane, is produced when microorganisms decompose organic matter in the absence of oxygen. Although cold plasmas have been used to recycle carbon from biogas in the past, it was restricted to producing simple hydrocarbons.
• In July 2023, Science-driven skincare brand Perricone MD launched a Cold Plasma Plus+ Lip Therapy, adding to its multi-tasking Cold Plasma Plus+ collection. The new treatment features the brand's proprietary liquid crystal delivery system for faster and deeper penetration of key ingredients into the skin's surface. It also includes peptides, omega fatty acids, and hyaluronic acid.

Frequently Asked Questions